NOxCOPD is AIT’s application for treatment of Chronic Obstructive Pulmonary Disease (COPD).
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by the obstruction of the airways, making it hard to breathe. Typically, patients show chronic inflammation of the airways, lung tissue and pulmonary blood vessels, causing the narrowing of the small airways. Increased airway inflammation causes frequent exacerbations of the disease.
As Nitric Oxide has been found effective against several causes of inflammation, we believe our formulation can be an effective treatment for COPD symptoms.
Our NOxCOPD application is based on proprietary technology of Nitric Oxide inhalation.
We are currently preparing for phase II trials of NOxCOPD.